LIGELIZUMAB ACHIEVES FREEDOM FROM DISEASE ACTIVITY IN CHRONIC SPONTANEOUS URTICARIA REGARDLESS OF PREVIOUS H1-ANTIHISTAMINE DOSE

被引：0
|
作者：
Soong, W.
Sitz, K.
Bernstein, J.
Maurer, M.
Gimenez-Arnau, A.
Hua, E.
Severin, T.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2021年 / 127卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P049
引用
收藏
页码：S27 / S28
页数：2
相关论文
共 50 条
  • [31] The efficacy and safety of the up-dosing of second-generation H1 antihistamine in treatment of chronic spontaneous urticaria in a paediatric population
    Sarti, L.
    Mori, F.
    Barni, S.
    Liccioli, G.
    Giovannini, M.
    Novembre, E.
    ALLERGY, 2019, 74 : 30 - 30
  • [32] Night-time sedating H1 antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled study
    Grattan, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (01) : 8 - 9
  • [33] A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria
    Saini, Sarbjit
    Rosen, Karin E.
    Hsieh, Hsin-Ju
    Wong, Dennis A.
    Conner, Edward
    Kaplan, Allen
    Spector, Sheldon
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (03) : 567 - U195
  • [34] Efficacy and Safety of TLL-018 in Moderate to Severe Chronic Spontaneous Urticaria Patients with Inadequate Response to H1 Antihistamine: Results from a Phase b Study
    Lu, Qianjin
    Yang, Bin
    Liu, Lunfei
    Li, Linfeng
    Liu, Weijun
    Yao, Xu
    Man, Xiaoyong
    Chen, Aijun
    Shi, Yuling
    Ding, Yangfeng
    Sun, Qing
    Tao, Juan
    Liang, Chris
    Liu, Yong
    Liu, Donghua
    Sun, Peiyu
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB372 - AB372
  • [35] A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria
    Sharma, Vinod K.
    Singh, Saurabh
    Ramam, M.
    Kumawat, Mahesh
    Kumar, Rakesh
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2014, 80 (02): : 122 - 128
  • [36] The Added-on of Ziziphus jujube Syrup in the Treatment of Chronic Spontaneous Urticaria Resistant to Standard-Dose of Secondary- generation H1 Antihistamine: A Double-Blind Randomized Clinical Trial
    Zare, Hamid
    Nabavizdeh, Seyed Hesamedin
    Jaladat, Amir Mohamad
    Zarshenas, Mohamad Mehdi
    Moghtaderi, Mozhgan
    Basirat, Atefeh
    Nasri, Nahid
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2023, 48 (06) : 582 - 590
  • [37] H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study
    Maurer, M.
    Staubach, P.
    Raap, U.
    Richter-Huhn, G.
    Bauer, A.
    Rueff, F.
    Jakob, T.
    Yazdi, A. S.
    Mahler, V.
    Wagner, N.
    Lippert, U.
    Hillen, U.
    Schwinn, A.
    Pawlak, M.
    Behnke, N.
    Chaouche, K.
    Chapman-Rothe, N.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2017, 47 (05): : 684 - 692
  • [38] Real-world evidence from the AWARE study in Germany highlights the need for greater awareness of guideline recommendations for the treatment of patients with H1-antihistamine-refractory chronic spontaneous urticaria
    Maurer, M.
    Raap, U.
    Staubach, P.
    Richter-Huhn, G.
    Baemer, D.
    Chapman-Rothe, N.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 114 - 114
  • [39] Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial (vol 71, pg 1135, 2016)
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Brautigam, M.
    Canvin, J.
    Maurer, M.
    ALLERGY, 2017, 72 (09) : 1430 - 1430
  • [40] Risk factors of uncontrolled symptoms using the standard dose of second-generation H1-antihistamines in chronic spontaneous urticaria children
    Koosakulchai, Vanlaya
    Yuenyongviwat, Araya
    Sangsupawanich, Pasuree
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2022, 40 (02): : 121 - 125
12345